This HTML5 document contains 198 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n9http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n6https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q64299405
rdf:type
wikibase:Item
schema:description
im Mai 2019 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel наукова стаття, опублікована в травні 2019 artículu científicu espublizáu en xineru de 2019 scientific article published on 23 January 2019
p:P577
wds:Q64299405-EE96CEE4-6EC0-4094-BAEB-C9F5FECB5FF9 wds:Q64299405-2CA62709-CD2A-4035-944B-AAED183AB078
wdt:P577
2019-05-01T00:00:00Z 2019-01-23T00:00:00Z
p:P407
wds:Q64299405-463B3884-7F31-4DF8-A6E0-839AD1730DD4
wdt:P407
wd:Q1860
p:P2888
wds:Q64299405-433D0735-662A-4E9B-888D-2D5D426E7818
wdt:P2888
n6:s00125-019-4811-7
p:P2860
wds:Q64299405-5450A7FB-8CD3-4231-9045-F1257A59DF9B wds:Q64299405-5898F16B-4A15-47EA-AFB6-A6421FB8D075 wds:Q64299405-493898C3-AA6B-4E05-9799-D6C949015937 wds:Q64299405-4B762BF7-9148-4A68-90CD-6304B2855CFD wds:Q64299405-532E8F04-C1FB-4293-AB91-6F2E8A0A01CC wds:Q64299405-69ADE339-993D-41A3-9B33-32A41CB11497 wds:Q64299405-69F5ACDE-6B8C-43C2-80C4-A83902808B6E wds:Q64299405-6C13FAC5-8650-4808-8975-643C2CECB5E2 wds:Q64299405-637E0196-CE6C-4D14-849F-34B61D58A5B1 wds:Q64299405-6478B849-1465-4F5C-9956-13FB543D8FDE wds:Q64299405-67718ED8-2223-4DCD-AAD5-3A08B7FEBDD0 wds:Q64299405-68705D88-E6F0-4B74-8947-D7A9364F3C7D wds:Q64299405-81DCB18C-7803-4460-A0B5-EE52E382106A wds:Q64299405-86509F7C-1E12-4133-B98D-3C9B8B60D62F wds:Q64299405-6EEE72C6-615A-436A-AF92-BD23FDADFDEE wds:Q64299405-A31D1DC1-F53D-4486-B534-0D388D2668FA wds:Q64299405-8DC23B14-870B-4DD7-9A89-1C2D35117510 wds:Q64299405-9E7119EC-4A49-4B54-9E2E-EF40E708D26F wds:Q64299405-11C4DBB7-5385-42C9-BCEA-3166FC30C485 wds:Q64299405-01A950DD-22D5-4928-9BF8-08D1635AA731 wds:Q64299405-027625A1-EF09-499F-8BE1-E8DEC188A0E9 wds:Q64299405-0517C30D-8944-4C0C-81C0-D4B7970660B2 wds:Q64299405-0598A5ED-ADE3-42DF-9AAF-325DEEED8543 wds:Q64299405-281E350B-024B-472E-A11E-C4895DF9AA2F wds:Q64299405-295A47FF-75DA-43B3-9514-FBBB8D8A6235 wds:Q64299405-2A9108C2-1089-4AF5-BAD7-59ECD6170CB1 wds:Q64299405-2B4DCD75-031A-4374-8C68-2B461C7C5B3D wds:Q64299405-22E9501A-1CAD-462C-9E56-0BC0F498A0C1 wds:Q64299405-23C2392C-96CA-4ADC-8EFC-2124C932F2A6 wds:Q64299405-37B69D1C-D931-45DA-BD08-82F58BC1D683 wds:Q64299405-39DF8875-79E1-41B8-950B-7F9705B331AA wds:Q64299405-3B13837F-ECD8-49C2-A65B-968CB5333D80 wds:Q64299405-3B92F28E-ACF2-4A2C-B10F-7EF3A824F24D wds:Q64299405-2F6D6B30-46CE-466B-A695-E7C7AEC00F18 wds:Q64299405-318C2D2C-89E6-4C0D-B669-9EE6375AF222 wds:Q64299405-37A2B08D-6783-4D05-9D1F-0208A8709ADA wds:Q64299405-47E681E3-7EF9-44DC-89D1-8D5298DEF538 wds:Q64299405-429D09C2-B1FB-4B0A-87AF-1E2E8B06DE53 wds:Q64299405-45529D7A-B2D6-4952-86F7-50DC5F86D83F wds:Q64299405-BE34F446-9825-486D-BC47-7AAE9E6EB9DE wds:Q64299405-BED5C584-67CA-4023-ACD7-45E863749352 wds:Q64299405-C05CEDDF-E0D7-40CC-A3B9-FCD2AFBC62C0 wds:Q64299405-A6849327-3E7E-4411-8275-45496EF0E48D wds:Q64299405-B899AB0C-DD68-4A25-A082-4449064F91AF wds:Q64299405-B9E318E0-1989-423E-9AA9-D36CD819ED17 wds:Q64299405-D34F63DB-96A5-40D5-B5CE-8B975976B9D9 wds:Q64299405-D544E06C-E014-4B15-A1EC-005FE1E11ECC wds:Q64299405-D83FDD55-E243-41D3-83CF-06CEFA21F25E wds:Q64299405-C27FFE26-940E-49C3-8C1E-D09C07C2023F wds:Q64299405-C4F4E839-5806-4582-8BE0-8BFA44AF086E wds:Q64299405-C7C48A3C-34E5-4EE9-AF6D-4E58C7D3F7A8 wds:Q64299405-CE280E7F-F9C2-4FD6-BE1D-02F210EDF370 wds:Q64299405-EA919694-688B-4FB2-B604-0DEFB58DF871 wds:Q64299405-EB41F1AB-0117-444E-A0E6-3FA228806BC0 wds:Q64299405-ED0F9967-400F-4655-B74E-30E4DAD8D0AA wds:Q64299405-DD4F2F64-3CB8-42F7-AFC1-957E9A33D135 wds:Q64299405-E044A45A-6547-4B5A-B73D-49266C94955A wds:Q64299405-E515FFF0-CFDF-4205-BF9E-F88E7FDE74C0 wds:Q64299405-E7A40F93-7150-4C3A-AE3B-904BCE437DD2
wdt:P2860
wd:Q33603880 wd:Q24673078 wd:Q38655765 wd:Q49205780 wd:Q52641093 wd:Q34041550 wd:Q33788804 wd:Q34042503 wd:Q41759880 wd:Q79740642 wd:Q42257763 wd:Q38537693 wd:Q42200757 wd:Q38637035 wd:Q40219549 wd:Q57920473 wd:Q38895423 wd:Q34648219 wd:Q41676983 wd:Q50194551 wd:Q38765352 wd:Q38729728 wd:Q45324653 wd:Q41692797 wd:Q34525819 wd:Q28277745 wd:Q39238492 wd:Q74034041 wd:Q37659402 wd:Q37471784 wd:Q36319703 wd:Q45754853 wd:Q38589318 wd:Q50965572 wd:Q39613796 wd:Q44427405 wd:Q57449051 wd:Q64378313 wd:Q48004838 wd:Q40118654 wd:Q38918678 wd:Q35766884 wd:Q45964157 wd:Q34355318 wd:Q34366531 wd:Q37115645 wd:Q38134107 wd:Q40548649 wd:Q38058245 wd:Q40378306 wd:Q55490730 wd:Q35691070 wd:Q34043114 wd:Q34957941 wd:Q90216579 wd:Q85824971 wd:Q39306213 wd:Q57920489 wd:Q35220557
p:P2093
wds:Q64299405-484AD8AB-811A-4D67-A92B-B6A991A54180 wds:Q64299405-0E45F1AF-FE4A-4A57-8467-0C1E9AA48773 wds:Q64299405-15B715DB-5ED4-4015-8017-A2A9A8694708 wds:Q64299405-16226A5A-8045-485D-8B1B-91F0A42177DF wds:Q64299405-7C94E0D5-22E0-4EBA-A1E1-80F30D3487FE wds:Q64299405-7BF9631A-9C6D-4349-B0E9-28414BB75492 wds:Q64299405-865D45E5-4569-43ED-A64F-4EDEE217400E wds:Q64299405-D440386B-F031-43A6-8379-B6A2428004DF
wdt:P2093
Knut Dahl-Jørgensen Mark A Atkinson Jessica L Dunne Richard A Insel Alberto Pugliese Heikki Hyöty Richard E Lloyd Åke Lernmark
rdfs:label
Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes
skos:prefLabel
Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes
schema:name
Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes
p:P50
wds:Q64299405-FB536E9A-45CA-4CD5-B15A-EB0E8ED96B7A wds:Q64299405-FDEF9869-A782-4719-B3C3-681FD85E9807 wds:Q64299405-B9A507D8-168C-49DD-904B-932EAD427F04 wds:Q64299405-BE5650AC-95FE-4AFD-A88D-8AB5B8C2448B
wdt:P50
wd:Q52938056 wd:Q60715750 wd:Q55396222 wd:Q40817610
p:P1476
wds:Q64299405-A23CDC89-2994-4950-97A8-CD5703611D20
wdt:P1476
Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes
p:P304
wds:Q64299405-51C5AFCA-9745-47E0-8221-0052A7BBFE8C
wdt:P304
744-753
p:P31
wds:Q64299405-A1CC1334-775E-4EB5-B6EC-587F94FCE0EE wds:Q64299405-5568CA4B-203B-4FB9-B850-AC87324FAA7C
wdt:P31
wd:Q13442814 wd:Q7318358
p:P921
wds:Q64299405-8CC6A76A-7B63-47BD-ABFB-95B89479F1D0 wds:Q64299405-159B5CDD-3B53-4519-85E6-4EEAEDBBD685 wds:Q64299405-3E01178C-6BC5-4CD8-85BD-338E7CD9A4B7 wds:Q64299405-6DDD7687-561D-4AC2-9945-2DD74BB70B0C wds:Q64299405-A27C63B4-6E4A-4CD7-8FA2-A170234AC973
wdt:P921
wd:Q57181755 wd:Q124407 wd:Q18967413 wd:Q19000403 wd:Q40207875
p:P698
wds:Q64299405-94AAD36E-B1D6-4008-86F6-4B91DBE84629
wdtn:P698
n10:30675626
wdt:P698
30675626
p:P1433
wds:Q64299405-60D6C79C-54F5-43C0-939A-E141AD011454
wdt:P1433
wd:Q5270140
p:P433
wds:Q64299405-94B74678-9AA5-4A35-8E96-8B86CEE54AE2
p:P478
wds:Q64299405-EE37534F-B442-4110-88AA-1EF9A6C9A8BC
wdt:P433
5
wdt:P478
62
p:P356
wds:Q64299405-7C858EC9-78DB-4964-ADFE-87990D9AD9E0
wdtn:P356
n9:S00125-019-4811-7
wdt:P356
10.1007/S00125-019-4811-7
p:P275
wds:Q64299405-069284BD-812D-4AE7-A319-40A7E1FA2ED2
wdt:P275
wd:Q20007257
p:P6179
wds:Q64299405-459E5925-9401-41F0-B9D1-9CCD8B39B974
wdt:P6179
1111623912
p:P932
wds:Q64299405-F8578BD0-1EC5-4116-B1D8-5E5FD61CD30B
wdt:P932
6450860